Article
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2
10 Jul 2025
Abstract excerpt
In search for broad-spectrum antivirals, we discover a small molecule inhibitor, RMC-113, that potently suppresses the replication of multiple RNA viruses including SARS-CoV-2 in human lung organoids. We demonstrate selective inhibition of the lipid kinases PIP4K2C and PIKfyve by RMC-113 and target engagement by its clickable analog. Lipidomics analysis reveals alteration of SARS-CoV-2-induced phosphoinositide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
